- Trial to inform the disease progression of individuals with BMD - “The severity and progression of symptoms common in BMD, like progressive muscle weakness, vary from person to person and have posed ...

Add Yahoo as a preferred source to see more of our stories on Google. Abi Brasch remembers her childhood through the nightly conversations she shared with her roommate and sister, Lily. In between ...

WALTHAM, Mass.--(BUSINESS WIRE)--Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced its support for the ReSolve study, ...

“Today, we’re going to make history,” said 18-year-old Eric Ramos on the day doctors operated on his ailing heart. Eric, who has Duchenne muscular dystrophy, is one of only three patients in the ...

For Duchenne and Becker muscular dystrophies, muscle biopsy may show whether dystrophin, a muscle protein, is missing or abnormal, and DNA testing is used to analyze the condition of the related gene.

The muscular dystrophies represent disorders of progressive muscular degeneration and weakness. As a group, they exhibit clinical heterogeneity that reflects diverse molecular mechanisms responsible ...

"Today, we're going to make history," said 18-year-old Eric Ramos on the day UT Southwestern Medical Center doctors operated on his ailing heart. Eric, who has Duchenne muscular dystrophy, is one of ...

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the ...

Abi Brasch remembers her childhood through the nightly conversations she shared with her roommate and sister, Lily. In between giggles, Lily Brasch would talk about her dreams, including the one where ...

DALLAS – March 26, 2014 – "Today, we're going to make history," said 18-year-old Eric Ramos on the day UT Southwestern Medical Center doctors operated on his ailing heart. Eric, who has Duchenne ...